EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 392 (2024) MATEC Web Conf., 392 (2024) 01107 References
Open Access
Issue
MATEC Web Conf.
Volume 392, 2024
International Conference on Multidisciplinary Research and Sustainable Development (ICMED 2024)
Article Number 01107
Number of page(s) 12
DOI https://doi.org/10.1051/matecconf/202439201107
Published online 18 March 2024
  1. Noronha, Vanita, Rakesh Pinninti, Vijay M. Patil, Amit Joshi, and Kumar Prabhash. “Lung cancer in the Indian subcontinent.” South Asian journal of cancer, 5(03), 095-103 (2016). [CrossRef] [Google Scholar]
  2. Noronha, V., R. Dikshit, N. Raut, A. Joshi, C. S. Pramesh, K. George, J. P. Agarwal, A. Munshi, and K. Prabhash. “Epidemiology of lung cancer in India: Focus on the differences between non-smokers and smokers: A single-centre experience.” Indian journal of cancer, 49(1), 74-81 (2012). [CrossRef] [Google Scholar]
  3. Koul, Parvaiz A., Mubashir R. Hajni, Mushtaq A. Sheikh, Umar H. Khan, Azra Shah, Yasmin Khan, A. G. Ahangar, and Reyaz A. Tasleem. “Hookah smoking and lung cancer in the Kashmir valley of the Indian subcontinent.” Asian Pac J Cancer Prev, 12(2), 519-524 (2011). [Google Scholar]
  4. Viswanathan, R., Sen Gupta, and PV Krishna Iyer. “Incidence of primary lung cancer in India.” Thorax, 17(1), 73 (1962). [Google Scholar]
  5. Parikh, P. M., A. A. Ranade, Babu Govind, N. Ghadyalpatil, R. Singh, R. Bharath, G. S. Bhattacharyya et al. “Lung cancer in India: Current status and promising strategies.” South Asian journal of cancer, 5(03), 093-095 (2016). [CrossRef] [Google Scholar]
  6. Krishnamurthy, A., R. Vijayalakshmi, V. Gadigi, R. Ranganathan, and T. G. Sagar. “The relevance of “Nonsmoking-associated lung cancer” in India: A single-centre experience.” Indian Journal of Cancer, 49(1), 82-88 (2012). [CrossRef] [Google Scholar]
  7. Sahoo, Rashmita, V. Chitti Babu, Geeta V. Patil Okaly, Smitha Rao, Ashwini Nargund, E. Venkataswamy, Raghavendra Rao, and BS Ajai Kumar. “Screening for EGFR mutations in lung cancer, a report from India.” Lung cancer, 73(3), (2011) 316-319. [CrossRef] [Google Scholar]
  8. Singh, Navneet, Ashutosh N. Aggarwal, Dheeraj Gupta, Digambar Behera, and Surinder K. Jindal. “Unchanging clinico-epidemiological profile of lung cancer in north India over three decades.” Cancer epidemiology, 34 (1), 101-104 (2010). [CrossRef] [Google Scholar]
  9. Ganesh, B., S. Sushama, S. Monika, and P. Suvarna. “A case-control study of risk factors for lung cancer in Mumbai, India.” Asian Pac J Cancer Prev, 12(2), 357-62 (2011). [Google Scholar]
  10. Gupta, Ritu, KK Mueen Ahmed, B. M. Gupta, and Madhu Bansal. “Lung cancer in India: A scientometric study of publications during 2005–14.” International Journal of Medicine and Public Health, 6(4), (2016). [Google Scholar]
  11. Dey, A., D. Biswas, S. K. Saha, S. Kundu, and A. Sengupta. “Comparison study of clinicoradiological profile of primary lung cancer cases: An Eastern India experience.” Indian journal of cancer, 49(1), 89-95 (2012). [CrossRef] [Google Scholar]
  12. Malik, Prabhat Singh, Mehar Chand Sharma, Bidhu Kalyan Mohanti, N. K. Shukla, S. V. S. Deo, Anant Mohan, Guresh Kumar, and Vinod Raina. “Clinico-pathological profile of lung cancer at AIIMS: A changing paradigm in India.” Asian pacific journal of cancer prevention, 14(1), 489-494 (2013). [CrossRef] [Google Scholar]
  13. Mandal, Sanjeet Kumar, Thaudem Tomcha Singh, Takhenchangbam Dhaneshor Sharma, and Venkatesan Amrithalingam. “Clinico-pathology of lung cancer in a regional cancer center in Northeastern India.” Asian Pacific journal of cancer prevention, 14(12), 7277-7281 (2013). [CrossRef] [Google Scholar]
  14. Prabhakar, Bala, Pravin Shende, and Steffi Augustine. “Current trends and emerging diagnostic techniques for lung cancer.” Biomedicine & Pharmacotherapy, 106, 1586-1599 (2018). [CrossRef] [Google Scholar]
  15. Rapiti, Elisabetta, Surinder K. Jindal, Dheeraj Gupta, and Paolo Boffetta. “Passive smoking and lung cancer in Chandigarh, India.” Lung Cancer, 23(3), 183-189 (1999). [CrossRef] [Google Scholar]
  16. Ungerleider, Leslie G., and James V. Haxby. “‘What’and ‘where’in the human brain.” Current opinion in neurobiology, 4(2) 157-165 (1994). [CrossRef] [Google Scholar]
  17. Weiner, Stephen, and Wolfie Traub. “Bone structure: from ångstroms to microns.” The FASEB journal, 6(3), 879-885 (1992). [CrossRef] [Google Scholar]
  18. Parker, George A., and Catherine A. Picut. “Liver immunobiology.” Toxicologic Pathology 33(1), 52-62 (2005). [CrossRef] [Google Scholar]
  19. Hardy, James D., Watts R. Webb, Martin L. Dalton, and George R. Walker. “Lung homotransplantation in man: report of the initial case.” Jama, 186(12), 1065-1074 (1963). [CrossRef] [Google Scholar]
  20. Rosol, Thomas J., John T. Yarrington, John Latendresse, and Charles C. Capen. “Adrenal gland: structure, function, and mechanisms of toxicity.” Toxicologic pathology, 29(1), 41-48 (2001). [CrossRef] [Google Scholar]
  21. Alamri, Alexander, Pennylouise Hever, Jebet Cheserem, Catia Gradil, Sanj Bassi, and Christos M. Tolias. “Encephaloduroateriosynangiosis (EDAS) in the management of moyamoya syndrome in children with sickle cell disease.” British journal of neurosurgery, 33(2), 161-164 (2019). [CrossRef] [Google Scholar]
  22. Fujita, Katsuzo, Norihiko Tamaki, and Satoshi Matsumoto. “Surgical treatment of moyamoya disease in children: which is more effective procedure, EDAS or EMS?.” Child’s Nervous System, 2(3), 134-138 (1986). [CrossRef] [Google Scholar]
  23. Ross, Ian B., Michael I. Shevell, Jose L. Montes, Bernard Rosenblatt, Gordon V. Watters, Jean-Pierre Farmer, and Augustin M. O’Gorman. “Encephaloduroarteriosynangiosis (EDAS) for the treatment of childhood moyamoya disease.” Pediatric neurology, 10(3), 199-204 (1994). [CrossRef] [Google Scholar]
  24. Suzuki, Ryuta, Yoshiharu Matsushima, Yoshiaki Takada, Tadashi Nariai, Shin-ichi Wakabayashi, and Osamu Tone. “Changes in cerebral hemodynamics following encephalo-duro-arterio-synangiosis (EDAS) in young patients with moyamoya disease.” Surgical neurology, 31(5), 343-349 (1989). [CrossRef] [Google Scholar]
  25. Fryer, Robert H., Richard C. Anderson, Claudia A. Chiriboga, and Neil A. Feldstein. “Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.” Pediatric neurology, 29(2), 124-130 (2003). [CrossRef] [Google Scholar]
  26. Matsushima, T., S. Fujiwara, S. Nagata, K. Fujii, M. Fukui, K. Kitamura, and K. Hasuo. “Surgical treatment for paediatric patients with moyamoya disease by indirect revascularization procedures (EDAS, EMS, EMAS).” Acta neurochirurgica, 98(3), 135-140 (1989). [CrossRef] [Google Scholar]
  27. Guo, Xiang, Xuexia Yuan, Lingyun Gao, Yueqin Chen, Hao Yu, Weijian Chen, Yunjun Yang et al. “Encephaloduroarteriosynangiosis (EDAS) treatment of moyamoya syndrome: evaluation by computed tomography perfusion imaging.” European Radiology, 1-10 (2021). [Google Scholar]
  28. Mishra, Arunodaya Raj, Abbas Mardani, Pratibha Rani, and Edmundas Kazimieras Zavadskas. “A novel EDAS approach on intuitionistic fuzzy set for assessment of healthcare waste disposal technology using new parametric divergence measures.” Journal of Cleaner Production, 272, 122807 (2020). [CrossRef] [Google Scholar]
  29. Wei, Guiwu, Cun Wei, and Yanfeng Guo. “EDAS method for probabilistic linguistic multiple attributes group decision making and their application to green supplier selection.” Soft Computing, 25(14), 9045-9053 (2021). [CrossRef] [Google Scholar]
  30. Yanmaz, Ozgur, Yakup Turgut, Emine Nisa Can, and Cengiz Kahraman. “Intervalvalued Pythagorean fuzzy EDAS method: an application to car selection problem.” Journal of Intelligent & [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.